Clinical Trial Update: Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing whether adding sitagliptin and empagliflozin to metformin affects high-sensitivity C-reactive protein levels in patients with T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: University of Lahore | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED